Actuate Therapeutics competitors and similar companiesClear all

Actuate Therapeutics's competitors and similar companies include GlycoMimetics, Corvus Pharmaceuticals, Immunovative Therapies and Luye Pharma.
Actuate Therapeutics
Actuate Therapeutics
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases.
GlycoMimetics
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Corvus Pharmaceuticals
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
Immunovative Therapies
Immunovative Therapies
Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases.
Luye Pharma
Luye Pharma
Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.
Founding Date
Founding Date
2015
Founding Date
2003
Founding Date
2014
Founding Date
2004
Founding Date
1994
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Fort Worth, US HQ
Dublin, IE
Locations
Rockville, US HQ
Locations
Burlingame, US HQ
Locations
Jerusalem, IL HQ
Locations
CN HQ
Employees
Employees
811% decrease
Employees
5025% increase
Employees
4911% decrease
Employees
11
Employees
5,0054% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
123.4 m
Valuation ($)
141.6 m
Valuation ($)
N/A
Valuation ($)
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
N/A
Employee Rating
N/A

Financial

Net income
Net income
N/A
Net income
($46.7m) (FY, 2022)
Net income
($41.3m) (FY, 2021)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 31.2m
Total funding raised
$ 101.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase

GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.

View company
Corvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.

View company
Immunovative Therapies
HQ
Jerusalem, IL
Employees
11

Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases.

View company
Luye Pharma
HQ
CN
Employees
5,005↑ 4% increase

Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.

View company